Wednesday, April 11, 2018 5:16:29 PM
Q4 2017 Sales in the IT segment grew to $11.1Mil up from 10.8 in Q3.
VHC-IT Backlog is $11.4Mil up from $10.4 at end of Q3.
Total IT backlog is $59.3Mil up by $16.5Mil YOY (Not sure this was given in Q3)
Deferred revenue in Professional Sales is $22.1 Mil up from $21Mil in Q3 representing $44.2Mil in orders.
By looking at deferred revenue plus IT backlog VASO has a total backlog of $103.5Mil.
Cash at year end 2017 was $5.5 Mil and company states cash in March was $9Mil.
Recent VASO News
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 03/06/2024 09:58:30 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/11/2023 07:10:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:00:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM